292 related articles for article (PubMed ID: 9105085)
1. Eosinophil chemotaxis inhibited by 5-lipoxygenase blockade and leukotriene receptor antagonism.
Muñoz NM; Douglas I; Mayer D; Herrnreiter A; Zhu X; Leff AR
Am J Respir Crit Care Med; 1997 Apr; 155(4):1398-403. PubMed ID: 9105085
[TBL] [Abstract][Full Text] [Related]
2. Blockade of eosinophil migration by 5-lipoxygenase and cyclooxygenase inhibition in explanted guinea pig trachealis.
Muñoz NM; Leff AR
Am J Physiol; 1995 Mar; 268(3 Pt 1):L446-54. PubMed ID: 7900826
[TBL] [Abstract][Full Text] [Related]
3. Formation of LTB4 by fMLP-stimulated alveolar macrophages accounts for eosinophil migration in vitro.
Hidi R; Coëffier E; Vargaftig BB
J Leukoc Biol; 1992 May; 51(5):425-31. PubMed ID: 1318347
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
Jackson WT; Froelich LL; Boyd RJ; Schrementi JP; Saussy DL; Schultz RM; Sawyer JS; Sofia MJ; Herron DK; Goodson T; Snyder DW; Pechous PA; Spaethe SM; Roman CR; Fleisch JH
J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783
[TBL] [Abstract][Full Text] [Related]
5. Contribution of leukotriene B4 to airway inflammation and the effect of antagonists.
Richards IM; Sun FF; Taylor BM; Shields SK; Griffin RL; Morris J; Wishka DG; Smith HW; Johnson RA; Dunn CJ
Ann N Y Acad Sci; 1991; 629():274-87. PubMed ID: 1659282
[TBL] [Abstract][Full Text] [Related]
6. Specific inhibition of leukotriene B4-induced neutrophil activation by LY223982.
Jackson WT; Boyd RJ; Froelich LL; Mallett BE; Gapinski DM
J Pharmacol Exp Ther; 1992 Dec; 263(3):1009-14. PubMed ID: 1335049
[TBL] [Abstract][Full Text] [Related]
7. Biological activity of leukotriene B4 analogs: inhibition of guinea pig eosinophil migration in vitro by the 2,6-disubstituted pyridine analogs U-75,302 and U-75,485.
Taylor BM; Crittenden NJ; Bruden MN; Wishka DG; Morris J; Richards IM; Sun FF
Prostaglandins; 1991 Sep; 42(3):211-24. PubMed ID: 1664113
[TBL] [Abstract][Full Text] [Related]
8. Leukotriene B4-activated human endothelial cells promote transendothelial neutrophil migration.
Nohgawa M; Sasada M; Maeda A; Asagoe K; Harakawa N; Takano K; Yamamoto K; Okuma M
J Leukoc Biol; 1997 Aug; 62(2):203-9. PubMed ID: 9261334
[TBL] [Abstract][Full Text] [Related]
9. Effects of the cysteinyl leukotriene receptor antagonists pranlukast and zafirlukast on tracheal mucus secretion in ovalbumin-sensitized guinea-pigs in vitro.
Liu YC; Khawaja AM; Rogers DF
Br J Pharmacol; 1998 Jun; 124(3):563-71. PubMed ID: 9647482
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the heterogeneous membrane potential response of neutrophils to N-formyl-methionyl-leucyl-phenylalanine (FMLP) by leukotriene B4: evidence for cell recruitment.
Fletcher MP
J Immunol; 1986 Jun; 136(11):4213-9. PubMed ID: 3009618
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.
Goldman DW; Enkel H; Gifford LA; Chenoweth DE; Rosenbaum JT
J Immunol; 1986 Sep; 137(6):1971-6. PubMed ID: 3018083
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate.
Bruijnzeel PL; Warringa RA; Kok PT; Kreukniet J
Br J Pharmacol; 1990 Apr; 99(4):798-802. PubMed ID: 2163279
[TBL] [Abstract][Full Text] [Related]
13. The effect of leukotriene B4, leukotriene C4, zymosan activated serum, histamine, tabanid extract and N-formyl-methionyl-leucyl-phenylalanine on the in vitro migration of equine eosinophils.
McEwen BJ; Wilcock BP; Eyre P
Can J Vet Res; 1990 Oct; 54(4):400-4. PubMed ID: 2174292
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the plasma membrane bound GTPase from rabbit neutrophils. I. Evidence for an Ni-like protein coupled to the formyl peptide, C5a, and leukotriene B4 chemotaxis receptors.
Feltner DE; Smith RH; Marasco WA
J Immunol; 1986 Sep; 137(6):1961-70. PubMed ID: 3018082
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological and immunohistochemical evidence for a functional nitric oxide synthase system in rat peritoneal eosinophils.
Zanardo RC; Costa E; Ferreira HH; Antunes E; Martins AR; Murad F; De Nucci G
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):14111-4. PubMed ID: 9391161
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of in vitro guinea pig eosinophil chemotaxis by leukotriene B4 antagonist U-75,302.
Taylor BM; Czuk CI; Brunden MN; Wishka DG; Morris J; Sun FF
Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():195-8. PubMed ID: 2546384
[No Abstract] [Full Text] [Related]
17. Effect of mode of activation of human eosinophils on tracheal smooth muscle contraction in guinea pigs.
Strek ME; White SR; Hsiue TR; Kulp GV; Williams FS; Leff AR
Am J Physiol; 1993 May; 264(5 Pt 1):L475-81. PubMed ID: 8498524
[TBL] [Abstract][Full Text] [Related]
18. Identification on receptors for leukotriene B4 expressed on guinea-pig peritoneal eosinophils.
Sehmi R; Rossi AG; Kay AB; Cromwell O
Immunology; 1992 Sep; 77(1):129-35. PubMed ID: 1328044
[TBL] [Abstract][Full Text] [Related]
19. Various authentic chemoattractants mediating leukocyte adherence inhibition.
Thomson DM
J Natl Cancer Inst; 1984 Sep; 73(3):595-605. PubMed ID: 6088878
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Leukotriene B4 Action Mitigates Intracerebral Hemorrhage-Associated Pathological Events in Mice.
Hijioka M; Anan J; Ishibashi H; Kurauchi Y; Hisatsune A; Seki T; Koga T; Yokomizo T; Shimizu T; Katsuki H
J Pharmacol Exp Ther; 2017 Mar; 360(3):399-408. PubMed ID: 28035009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
